300791SZSE

Announcement on the Results of the Buyback of Xianle Convertible Bonds

Sirio Pharma Co., Ltd.·

✨ AI Summary

Xianle Health Technology Co., Ltd. announced that during the buyback period from March 30 to April 3, 2026, no valid buyback applications were received for the Xianle Convertible Bonds. The buyback price was set at RMB 101.890 per bond. As a result, the company will not need to process any buyback payments, and the financial status and operations of the company remain unaffected.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement on the Results of the Buyback of Xianle Convertible Bonds

Xianle Health Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, without any false records, misleading statements, or significant omissions.

Special Reminder:

  1. Bond abbreviation: Xianle Convertible Bonds
  2. Bond code: 123113
  3. Buyback price: RMB 101.890 per bond (including interest and tax)
  4. Buyback application period: March 30, 2026, to April 3, 2026
  5. Valid buyback application quantity: 0 bonds
  6. Buyback amount: RMB 0 (including interest and tax)

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing